- AI for RNA biology and target discovery
- Built specifically for precision medicine teams, not bolt-on AI
- Scales to organization-wide healthcare rollouts
Deep Genomics
AI for RNA biology and targets
SF7.1
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Interpret genomic test results in contextRNA therapeutics research programs
Interpret genomic test results in contextRNA therapeutics research programs
Best for
RNA therapeutics research programs
Pricing
Custom
SoftFinders Score
7.1 / 10
Overview
What is Deep Genomics?
Deep Genomics is an AI company using machine learning to discover RNA-targeted therapies and understand genetic disease biology. The product is positioned around genomic interpretation and precision care support rather than standalone test results, and clinical context remains essential for every care decision made from genomic insights. Buyers should confirm test menu, turnaround time, EHR result delivery, and clinical interpretation support before adopting across precision medicine programs and active oncology service lines today.
For RNA therapeutics research programs, Deep Genomics is worth a serious look thanks to AI for RNA biology and target discovery. Just keep one limitation in view: engagement is research and pipeline-led. Pricing is sales-led and scoped per buyer rather than posted publicly. Verify EHR or workflow fit, scope, and support before committing.
KEY FEATURES
What you get out of the box
Genomic Interpretation
Interprets genomic test results in context
Multiomics Analysis
Analyzes multiple omics data layers together
Cancer Detection
Supports early cancer detection workflows
Biomarker Discovery
Tools to surface biomarker signals
Clinical Trials
Connects insights with clinical trial options
Precision Care
Supports precision care decisions across patients
USE CASES
Where teams put it to work
Interpret genomic test results in context
Support early cancer detection programs
Surface biomarker signals across data
Connect genomic insights with care decisions
Support precision oncology workflows
Bridge genomic data and clinical trials
Editorial Take
What we like, and what to verify
- Engagement is research and pipeline-led
- Clinical interpretation required for every result
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Verge Genomics SF 7.1
Why consider it
Human-data-first genomics drug discovery
Inflammatix SF 7.2
Why consider it
Gene-signature readouts for infection testing
Variantyx SF 7
Why consider it
Whole-genome analytics for clinical diagnosis
Genome Medical SF 7.1
Why consider it
Tech-enabled genetic counseling and testing network
Sully.ai SF 7.6
Why consider it
All-in-one AI scribe and clinician assistant
Tali AI SF 7.5
Why consider it
Voice AI scribe with built-in medical search
FAQ